Outset Medical, Inc.

NasdaqGS:OM Stock Report

Market Cap: US$155.1m

Outset Medical Future Growth

Future criteria checks 1/6

Outset Medical is forecast to grow earnings and revenue by 14.2% and 14.3% per annum respectively while EPS is expected to grow by 20.2% per annum.

Key information

14.2%

Earnings growth rate

20.2%

EPS growth rate

Medical Equipment earnings growth16.3%
Revenue growth rate14.3%
Future return on equityn/a
Analyst coverage

Good

Last updated17 Apr 2024

Recent future growth updates

Recent updates

Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%

Feb 14
Not Many Are Piling Into Outset Medical, Inc. (NASDAQ:OM) Stock Yet As It Plummets 29%

Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors

Jun 09
Outset Medical, Inc.'s (NASDAQ:OM) Earnings Haven't Escaped The Attention Of Investors

Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital

Sep 20

Outset Medical awarded VA contract for hemodialysis

Aug 15

Outset Medical jumps 24% after 2Q results as FDA clears hemodialysis system

Aug 01

Outset Medical: Margins Leave No Tangible Value Flow, Pricing 18% Downside

Jul 06

Outset Medical Grows Revenue But Operating Losses Remain High

Dec 29

Earnings and Revenue Growth Forecasts

NasdaqGS:OM - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026208-115N/AN/A5
12/31/2025174-122N/AN/A8
12/31/2024148-130N/AN/A8
12/31/2023130-173-135-131N/A
9/30/2023132-176-146-141N/A
6/30/2023129-170-148-142N/A
3/31/2023118-170-160-152N/A
12/31/2022115-163-154-146N/A
9/30/2022112-163-151-144N/A
6/30/2022110-152-143-138N/A
3/31/2022110-139-134-130N/A
12/31/2021103-132-133-130N/A
9/30/202192-123-128-123N/A
6/30/202179-135-130-124N/A
3/31/202166-131-120-113N/A
12/31/202050-79-108-99N/A
9/30/202040-67-95-88N/A
6/30/202029-41-82-76N/A
3/31/202020-40-82-77N/A
12/31/201915-85-74-70N/A
12/31/20182-73-48-46N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: OM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: OM's revenue (14.3% per year) is forecast to grow faster than the US market (8.2% per year).

High Growth Revenue: OM's revenue (14.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OM's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.